Claudine Prowse, PhD
SVP, Corporate Development & IRO
Claudine Prowse joined Rocket in 2018 as SVP, Head of Investor Relations and Corporate Development. Prior to this role, she was Vice President of Strategy, Corporate Development and IRO at Inotek, where she identified and spearheaded the merger transaction with Rocket Pharma.
Claudine has 18 years of experience in the biotechnology industry spanning small, mid and large cap biotech companies. She served in similar Strategy and Investor Relations roles at Inotek, Biogen, Human Genome Sciences; and Ionis Pharmaceuticals, as well as Vice President and Product Manager of Medacorp, Leerink Swann.
Claudine holds a BS in Biomedical Engineering from the University of California, San Diego (UCSD) School of Engineering and a PhD in Biomedical Sciences from the UCSD School of Medicine. Claudine also has a passion for Tae Kwon Do, and has competed in various competitive sports activities.Back to Management